Table 3.

Patient Survival Related to Clinicopathologic Patient Characteristics

Variable	No. of patients	No. of events	Survival, median (95% CI), mo	P value⁎
Sex				0.843
Male	233	199	12.1 (10.0–14.3)
Female	140	113	12.6 (9.5–15.6)
Age, years				0.338
<68	177	148	12.8 (9.9–15.8)
≥68	196	164	12.1 (10.2–14.0)
Pathologic tumor stage				<0.001†
pT1	37	15	50.5 (39.3–61.7)
pT2	34	24	21.9 (0–45.4)
pT3	150	129	13.6 (11.3–15.9)
pT4	151	143	8.3 (5.7–10.9)
Nodal status				<0.001†
pN0	82	48	34.7 (25.3–44.1)
pN1	52	43	15.5 (10.6–20.4)
pN2	69	61	16.4 (12.1–20.7)
pN3	166	156	8.0 (6.1–9.8)
Tumor stage				<0.001†
IA	13	11	50 (0–103)
IB	11	9	13 (0–27)
IIA	28	28	15.5 (0–35.2)
IIB	26	26	15.5 (9.1–21.9)
IIIA	36	36	12.1 (9.0–15.2)
IIIB	67	67	12.6 (9.9–15.3)
IIIC	54	54	4.8 (0.3–9.3)
IV	69	69	6.4 (4.5–8.4)
Tumor grade				<0.001
G1/G2	83	60	24.5 (14.3–34.7)
G3/G4	278	243	11.1 (9.2–13.0)
Laurén classification				0.052†
Intestinal	136	113	14.7 (10.2–19.1)
Diffuse	173	147	11.1 (8.8–13.5)
Mixed	36	29	9.4 (5.7–13.1)
ADAM17				0.805
Negative	267	225	12.1 (10.3–13.9)
Positive	97	82	12.7 (9.2–16.3)
FZD7				0.008
Negative	229	190	13.4 (10.9–15.8)
Positive	131	113	10.3 (7.6–12.9)

CI, confidence interval.

^⁎Log rank test.

^†Pooled over groups.